Healthcare Info Mei 12, 2018 US Edit FDA expands approval of Gilenya to treat multiple sclerosis in pediatric patients FDA expands approval of Gilenya to treat multiple sclerosis in pediatric patients FDA.gov FDA approves first drug to treat MS in children Healio Fingolimod OK'd for Pediatric MS MedPage TodayFull coverage Read More ... FDA expands approval of Gilenya to treat multiple sclerosis in pediatric patients published May 12, 2018 at 03:35AM. Original Source Link : https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm607501.htm loading...
0 Response to "FDA expands approval of Gilenya to treat multiple sclerosis in pediatric patients"
Posting Komentar